EYPT
Eyepoint Pharmaceuticals Inc
3.20$
-3.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2,055.6% | -90.1% | +18.8% | -45.1% | +142.3% | -0.5% | -23.0% | -32.0% | +402.5% | -17.6% | +258.3% | -65.2% | +244.1% | -13.3% | -45.0% | +280.8% | -54.6% | +2.7% | +23.1% | +0.5% | +27.4% | -19.5% | +24.4% | -13.4% | +5.2% | -27.1% | +18.5% | +67.0% | -7.7% | -16.7% | -18.9% | +11.0% | +10.1% | +111.0% | -78.2% | -81.9% | -35.8% | +12.3% | -27.2% | – | |
| – | -15.4% | +5.0% | +99.2% | -6.8% | -30.8% | -22.1% | +43.3% | +30.8% | -33.0% | -92.1% | +113.9% | -53.7% | +304.9% | -26.0% | -48.8% | +274.9% | +30.8% | -43.5% | +38.8% | -5.4% | +66.2% | -41.4% | -2.4% | -19.0% | +142.7% | -81.2% | +180.0% | -32.9% | -17.0% | -23.9% | +84.6% | -47.5% | +10.9% | -1.3% | -79.5% | +337.0% | -48.0% | +40.8% | -100.0% | – | |
| – | – | -197.4% | – | -45.1% | -966.5% | – | – | – | – | – | +286.7% | -66.5% | +235.0% | -10.9% | -44.4% | +281.6% | -66.2% | +27.0% | +19.4% | +2.1% | +17.7% | -11.7% | +30.8% | -12.5% | -17.2% | -1.1% | +3.8% | +91.4% | -6.9% | -16.2% | -26.1% | +21.2% | +10.1% | +119.5% | -78.1% | -95.3% | +0.0% | -31.4% | +201.8% | – | |
| – | -24.2% | +5.0% | +26.7% | -9.4% | +11.8% | -22.1% | +43.3% | +30.8% | -33.0% | -9.1% | +4.2% | -11.9% | +18.6% | +17.5% | -32.5% | +24.8% | +27.3% | +5.3% | +2.3% | +51.6% | +4.9% | +11.5% | +30.6% | -14.1% | +39.2% | -12.4% | +15.5% | +10.4% | +3.4% | +67.9% | -1.1% | -0.9% | +46.8% | +35.1% | -5.3% | -14.0% | +24.0% | +21.8% | +15.9% | – | |
| – | -11.7% | -16.3% | +8.2% | -2.0% | -3.9% | -7.7% | +85.0% | -1.4% | +13.9% | -2.7% | +4.4% | -9.3% | -4.9% | +5.1% | +9.9% | +21.0% | -0.3% | -11.5% | +1.3% | +16.9% | +52.1% | -7.3% | +0.1% | +7.7% | -7.8% | +8.8% | -2.0% | +16.6% | +6.6% | +25.4% | -9.6% | +1.7% | -2.9% | +10.2% | -14.5% | +22.2% | -21.4% | +33.9% | -6.6% | – | |
| – | -22.1% | -16.3% | +181.8% | -6.5% | -61.3% | +126.8% | +87.2% | +33.8% | -34.0% | +76.2% | +2.1% | -2.6% | +0.3% | +10.2% | -17.7% | +6.8% | +10.4% | -3.1% | +7.1% | +24.8% | +17.8% | -2.9% | +12.6% | -7.0% | +88.3% | -43.8% | +5.2% | -5.6% | +3.5% | +50.6% | -3.7% | -0.2% | +31.7% | +29.4% | -7.0% | -7.6% | +13.4% | +23.8% | +12.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -209.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -100.0% | – | +0.0% | +0.0% | +13.2% | +1.5% | +23.3% | +56.8% | +10.7% | +1.0% | -0.2% | +1.2% | +2.1% | -0.9% | -26.3% | +2.2% | +0.9% | +0.0% | -14.0% | -53.8% | +19.9% | +18.0% | +4.0% | -46.4% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -97.2% | +145.3% | -100.0% | – | -73.9% | -31.2% | +97.8% | -85.1% | -85.2% | -687.5% | – | – | – | -99.6% | +23,033.3% | +12.3% | -76.8% | -93.9% | +93,986.4% | -98.0% | -381.5% | – | -95.5% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -4,523.2% | – | – | – | – | – | – | – | -230.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.